• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen tes

tetano

Editor, Senior Moderator
J Infect Chemother


. 2022 Aug 8;S1341-321X(22)00220-3.
doi: 10.1016/j.jiac.2022.07.023. Online ahead of print.
Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection


Yoshihiro Fujiya[SUP] 1 [/SUP], Yuki Sato[SUP] 2 [/SUP], Yuki Katayama[SUP] 2 [/SUP], Shinya Nirasawa[SUP] 2 [/SUP], Mikako Moriai[SUP] 2 [/SUP], Masachika Saeki[SUP] 2 [/SUP], Yuki Yakuwa[SUP] 2 [/SUP], Ikumi Kitayama[SUP] 2 [/SUP], Koichi Asanuma[SUP] 2 [/SUP], Koji Kuronuma[SUP] 3 [/SUP], Satoshi Takahashi[SUP] 4 [/SUP]



Affiliations

Abstract

Introduction: Compared to nasopharyngeal swabs (NPS), there has been insufficient evaluation of the diagnostic performance of nasal swabs (NS) for the detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) in the nucleic acid amplification test (NAAT) and quantitative SARS-CoV-2 antigen test (QAT).
Methods: We prospectively compared healthcare worker-collected and flocked NS within nine days after symptom onset to paired NPS to detect SARS-CoV-2 in NAAT and QAT on the fully automated Lumipulse system. The agreement between sample types was evaluated, and cycle threshold (Ct) values and antigen levels were used as surrogate viral load measures.
Results: Sixty sets of NPS and NS samples were collected from 40 patients with COVID-19. The overall agreements between NAAT and QAT samples were 76.7% and 65.0%, respectively. In NAAT, the Ct value of NS was significantly higher, 5.9, than that of NPS. Thirty-nine (95.1%) NS tested positive in 41 positive-paired NPS with Ct ≤ 30. The negative correlation was observed between antigen levels of NS in QAT and Ct values of NS in NAAT (r = -0.88). In QAT, the antigen level of NS was significantly lower than that of NPS. Thirty-six (90.0%) NS tested positive in 40 positive-paired NPS with antigen levels > 100 pg/mL, which were collected significantly earlier than those with antigen levels ≤ 100 pg/mL.
Conclusions: In NAAT and QAT, NS had limited performance in detecting SARS-CoV-2 compared to NPS. However, NS may be helpful for patients with COVID-19 with high viral loads or those in the early stages of the illness.

Keywords: SARS-CoV-2; nasal swabs; nasopharyngeal swabs; nucleic acid amplification test; quantitative SARS-CoV-2 antigen test; viral load.
 
Back
Top Bottom